 | • レポートコード：QFJ1-5999 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ルフィナミドの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、経口懸濁液）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ルフィナミドの市場動向 ・企業の競争状況、市場シェア ・ルフィナミドの種類別市場規模と予測2016-2027（錠剤、経口懸濁液） ・ルフィナミドの用途別市場規模と予測2016-2027（成人、小児患者） ・ルフィナミドの北米市場規模2016-2027（アメリカ、カナダ） ・ルフィナミドの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ルフィナミドのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ルフィナミドの中南米市場規模2016-2027（メキシコ、ブラジル） ・ルフィナミドの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eisai、Glenmark Pharms、Mylan、West-ward Pharms） ・結論 |
Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders.
Market Analysis and Insights: Global Rufinamide Market
The global Rufinamide market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rufinamide market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rufinamide market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rufinamide market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rufinamide market.
Global Rufinamide Scope and Market Size
Rufinamide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rufinamide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tablets
Oral suspension
Segment by Application
Adults
Pediatric patients
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eisai
Glenmark Pharms
Mylan
West-ward Pharms
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rufinamide Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 Oral suspension
1.3 Market by Application
1.3.1 Global Rufinamide Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rufinamide Market Perspective (2016-2027)
2.2 Rufinamide Growth Trends by Regions
2.2.1 Rufinamide Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rufinamide Historic Market Share by Regions (2016-2021)
2.2.3 Rufinamide Forecasted Market Size by Regions (2022-2027)
2.3 Rufinamide Industry Dynamic
2.3.1 Rufinamide Market Trends
2.3.2 Rufinamide Market Drivers
2.3.3 Rufinamide Market Challenges
2.3.4 Rufinamide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rufinamide Players by Revenue
3.1.1 Global Top Rufinamide Players by Revenue (2016-2021)
3.1.2 Global Rufinamide Revenue Market Share by Players (2016-2021)
3.2 Global Rufinamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rufinamide Revenue
3.4 Global Rufinamide Market Concentration Ratio
3.4.1 Global Rufinamide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rufinamide Revenue in 2020
3.5 Rufinamide Key Players Head office and Area Served
3.6 Key Players Rufinamide Product Solution and Service
3.7 Date of Enter into Rufinamide Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rufinamide Breakdown Data by Type
4.1 Global Rufinamide Historic Market Size by Type (2016-2021)
4.2 Global Rufinamide Forecasted Market Size by Type (2022-2027)
5 Rufinamide Breakdown Data by Application
5.1 Global Rufinamide Historic Market Size by Application (2016-2021)
5.2 Global Rufinamide Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Rufinamide Market Size (2016-2027)
6.2 North America Rufinamide Market Size by Type
6.2.1 North America Rufinamide Market Size by Type (2016-2021)
6.2.2 North America Rufinamide Market Size by Type (2022-2027)
6.2.3 North America Rufinamide Market Size by Type (2016-2027)
6.3 North America Rufinamide Market Size by Application
6.3.1 North America Rufinamide Market Size by Application (2016-2021)
6.3.2 North America Rufinamide Market Size by Application (2022-2027)
6.3.3 North America Rufinamide Market Size by Application (2016-2027)
6.4 North America Rufinamide Market Size by Country
6.4.1 North America Rufinamide Market Size by Country (2016-2021)
6.4.2 North America Rufinamide Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Rufinamide Market Size (2016-2027)
7.2 Europe Rufinamide Market Size by Type
7.2.1 Europe Rufinamide Market Size by Type (2016-2021)
7.2.2 Europe Rufinamide Market Size by Type (2022-2027)
7.2.3 Europe Rufinamide Market Size by Type (2016-2027)
7.3 Europe Rufinamide Market Size by Application
7.3.1 Europe Rufinamide Market Size by Application (2016-2021)
7.3.2 Europe Rufinamide Market Size by Application (2022-2027)
7.3.3 Europe Rufinamide Market Size by Application (2016-2027)
7.4 Europe Rufinamide Market Size by Country
7.4.1 Europe Rufinamide Market Size by Country (2016-2021)
7.4.2 Europe Rufinamide Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Rufinamide Market Size (2016-2027)
8.2 Asia-Pacific Rufinamide Market Size by Type
8.2.1 Asia-Pacific Rufinamide Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rufinamide Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rufinamide Market Size by Type (2016-2027)
8.3 Asia-Pacific Rufinamide Market Size by Application
8.3.1 Asia-Pacific Rufinamide Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rufinamide Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rufinamide Market Size by Application (2016-2027)
8.4 Asia-Pacific Rufinamide Market Size by Region
8.4.1 Asia-Pacific Rufinamide Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rufinamide Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Rufinamide Market Size (2016-2027)
9.2 Latin America Rufinamide Market Size by Type
9.2.1 Latin America Rufinamide Market Size by Type (2016-2021)
9.2.2 Latin America Rufinamide Market Size by Type (2022-2027)
9.2.3 Latin America Rufinamide Market Size by Type (2016-2027)
9.3 Latin America Rufinamide Market Size by Application
9.3.1 Latin America Rufinamide Market Size by Application (2016-2021)
9.3.2 Latin America Rufinamide Market Size by Application (2022-2027)
9.3.3 Latin America Rufinamide Market Size by Application (2016-2027)
9.4 Latin America Rufinamide Market Size by Country
9.4.1 Latin America Rufinamide Market Size by Country (2016-2021)
9.4.2 Latin America Rufinamide Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rufinamide Market Size (2016-2027)
10.2 Middle East & Africa Rufinamide Market Size by Type
10.2.1 Middle East & Africa Rufinamide Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rufinamide Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rufinamide Market Size by Type (2016-2027)
10.3 Middle East & Africa Rufinamide Market Size by Application
10.3.1 Middle East & Africa Rufinamide Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rufinamide Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rufinamide Market Size by Application (2016-2027)
10.4 Middle East & Africa Rufinamide Market Size by Country
10.4.1 Middle East & Africa Rufinamide Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rufinamide Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eisai
11.1.1 Eisai Company Details
11.1.2 Eisai Business Overview
11.1.3 Eisai Rufinamide Introduction
11.1.4 Eisai Revenue in Rufinamide Business (2016-2021)
11.1.5 Eisai Recent Development
11.2 Glenmark Pharms
11.2.1 Glenmark Pharms Company Details
11.2.2 Glenmark Pharms Business Overview
11.2.3 Glenmark Pharms Rufinamide Introduction
11.2.4 Glenmark Pharms Revenue in Rufinamide Business (2016-2021)
11.2.5 Glenmark Pharms Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Rufinamide Introduction
11.3.4 Mylan Revenue in Rufinamide Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 West-ward Pharms
11.4.1 West-ward Pharms Company Details
11.4.2 West-ward Pharms Business Overview
11.4.3 West-ward Pharms Rufinamide Introduction
11.4.4 West-ward Pharms Revenue in Rufinamide Business (2016-2021)
11.4.5 West-ward Pharms Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Rufinamide Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets
Table 3. Key Players of Oral suspension
Table 4. Global Rufinamide Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Rufinamide Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Rufinamide Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Rufinamide Market Share by Regions (2016-2021)
Table 8. Global Rufinamide Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Rufinamide Market Share by Regions (2022-2027)
Table 10. Rufinamide Market Trends
Table 11. Rufinamide Market Drivers
Table 12. Rufinamide Market Challenges
Table 13. Rufinamide Market Restraints
Table 14. Global Rufinamide Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Rufinamide Market Share by Players (2016-2021)
Table 16. Global Top Rufinamide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rufinamide as of 2020)
Table 17. Ranking of Global Top Rufinamide Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Rufinamide Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Rufinamide Product Solution and Service
Table 21. Date of Enter into Rufinamide Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rufinamide Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Rufinamide Revenue Market Share by Type (2016-2021)
Table 25. Global Rufinamide Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Rufinamide Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Rufinamide Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Rufinamide Revenue Market Share by Application (2016-2021)
Table 29. Global Rufinamide Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Rufinamide Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Rufinamide Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Rufinamide Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Rufinamide Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Rufinamide Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Rufinamide Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Rufinamide Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Rufinamide Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Rufinamide Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Rufinamide Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Rufinamide Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Rufinamide Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Rufinamide Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Rufinamide Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Rufinamide Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Rufinamide Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Rufinamide Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Rufinamide Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Rufinamide Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Rufinamide Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Rufinamide Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Rufinamide Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Rufinamide Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Rufinamide Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Rufinamide Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Rufinamide Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Rufinamide Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Rufinamide Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Rufinamide Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Rufinamide Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Rufinamide Market Size by Country (2022-2027) & (US$ Million)
Table 61. Eisai Company Details
Table 62. Eisai Business Overview
Table 63. Eisai Rufinamide Product
Table 64. Eisai Revenue in Rufinamide Business (2016-2021) & (US$ Million)
Table 65. Eisai Recent Development
Table 66. Glenmark Pharms Company Details
Table 67. Glenmark Pharms Business Overview
Table 68. Glenmark Pharms Rufinamide Product
Table 69. Glenmark Pharms Revenue in Rufinamide Business (2016-2021) & (US$ Million)
Table 70. Glenmark Pharms Recent Development
Table 71. Mylan Company Details
Table 72. Mylan Business Overview
Table 73. Mylan Rufinamide Product
Table 74. Mylan Revenue in Rufinamide Business (2016-2021) & (US$ Million)
Table 75. Mylan Recent Development
Table 76. West-ward Pharms Company Details
Table 77. West-ward Pharms Business Overview
Table 78. West-ward Pharms Rufinamide Product
Table 79. West-ward Pharms Revenue in Rufinamide Business (2016-2021) & (US$ Million)
Table 80. West-ward Pharms Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rufinamide Market Share by Type: 2020 VS 2027
Figure 2. Tablets Features
Figure 3. Oral suspension Features
Figure 4. Global Rufinamide Market Share by Application: 2020 VS 2027
Figure 5. Adults Case Studies
Figure 6. Pediatric patients Case Studies
Figure 7. Rufinamide Report Years Considered
Figure 8. Global Rufinamide Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Rufinamide Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Rufinamide Market Share by Regions: 2020 VS 2027
Figure 11. Global Rufinamide Market Share by Regions (2022-2027)
Figure 12. Global Rufinamide Market Share by Players in 2020
Figure 13. Global Top Rufinamide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rufinamide as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Rufinamide Revenue in 2020
Figure 15. Global Rufinamide Revenue Market Share by Type (2016-2021)
Figure 16. Global Rufinamide Revenue Market Share by Type (2022-2027)
Figure 17. North America Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Rufinamide Market Share by Type (2016-2027)
Figure 19. North America Rufinamide Market Share by Application (2016-2027)
Figure 20. North America Rufinamide Market Share by Country (2016-2027)
Figure 21. United States Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Rufinamide Market Share by Type (2016-2027)
Figure 25. Europe Rufinamide Market Share by Application (2016-2027)
Figure 26. Europe Rufinamide Market Share by Country (2016-2027)
Figure 27. Germany Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Rufinamide Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Rufinamide Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Rufinamide Market Share by Region (2016-2027)
Figure 37. China Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Rufinamide Market Share by Type (2016-2027)
Figure 45. Latin America Rufinamide Market Share by Application (2016-2027)
Figure 46. Latin America Rufinamide Market Share by Country (2016-2027)
Figure 47. Mexico Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Rufinamide Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Rufinamide Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Rufinamide Market Share by Country (2016-2027)
Figure 53. Turkey Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Rufinamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Eisai Revenue Growth Rate in Rufinamide Business (2016-2021)
Figure 57. Glenmark Pharms Revenue Growth Rate in Rufinamide Business (2016-2021)
Figure 58. Mylan Revenue Growth Rate in Rufinamide Business (2016-2021)
Figure 59. West-ward Pharms Revenue Growth Rate in Rufinamide Business (2016-2021)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
世界のエトラビリン市場規模・現状・予測（2021年-2027年） Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etrav…- 世界の小児硝子体手術市場規模・現状・予測（2021年-2027年） Vitrectomy is the surgery performed to remove vitreous gel from the middle part of the eye. Market Analysis and Insights: Global Pediatric Vitrectomy Market The global Pediatric Vitrectomy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during …
- 世界の小児HIV感染症治療市場規模・現状・予測（2021年-2027年） Over 1.8 million children across the globe are affected from HIV, while only half of these have access to the antiretroviral therapy (ART), according to the UNICEF Market Analysis and Insights: Global Pediatric HIV Infection Treatment Market The global Pediatric HIV Infection Treatment market size i…
- 世界の小児灌流システム市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pediatric Perfusion System Market The global Pediatric Perfusion System market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …
- 世界の小児喘息治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pediatric Asthma Treatment Market The global Pediatric Asthma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …